278 related articles for article (PubMed ID: 16282731)
21. Two cases of complete response after imatinib mesylate treatment of advanced GIST.
Papaxoinis G; Nikolaou M; Lianos E; Gaglia A; Economopoulos T; Pectasides D
Anticancer Res; 2006; 26(6C):4869-72. PubMed ID: 17214353
[TBL] [Abstract][Full Text] [Related]
22. [A case of recurrent gastrointestinal stromal tumor of the stomach with complete response to imatinib mesilate].
Aoyama T; Saeki H; Samejima J; Fujii K; Ishikawa Y; Kawamoto M; Fujisawa J; Matsukawa H; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2009 Jun; 36(6):975-8. PubMed ID: 19542718
[TBL] [Abstract][Full Text] [Related]
23. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
Zhu J; Wang Y; Hou M; Li HY; Zhang J
Oncology; 2007; 73(5-6):324-7. PubMed ID: 18497504
[TBL] [Abstract][Full Text] [Related]
24. [Current aspects of treatment in gastrointestinal stromal tumors (GIST)].
Láng I; Hitre E
Orv Hetil; 2005 May; 146(18 Suppl 1):935-41. PubMed ID: 15921308
[TBL] [Abstract][Full Text] [Related]
25. Six months neoadjuvant imatinib improves resectability potential of gastric stromal tumors in Egyptian patients.
Saied GM; Kensarah AM
Int J Surg; 2010; 8(2):105-8. PubMed ID: 19944196
[TBL] [Abstract][Full Text] [Related]
26. [A case of gastric GIST treated preoperatively by imatinib mesylate].
Hiramatsu Y; Konno H; Kamiya K; Baba M; Ohta M; Kondo K; Yamamoto M; Kikuchi H; Tanaka T; Sugimura H; Nakamura S
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1219-23. PubMed ID: 15332547
[TBL] [Abstract][Full Text] [Related]
27. [Pathological complete response in a large gastric GIST that became resectable after neoadjuvant chemotherapy with imatinib mesylate].
Otsubo D; Sawa H; Fukuoka E; Murata K; Mii Y; Oka S; Iwatani Y; Kuroda D
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2402-4. PubMed ID: 25731537
[TBL] [Abstract][Full Text] [Related]
28. [A case of an elderly patient with recurrent GIST, which was effectively treated with low-dose imatinib mesylate].
Matsumoto S; Takahashi M; Ishizu H; Takahashi H; Masuko H; Tanaka K; Hata T; Yamagami H; Takahashi S; Tahara M; Ueki S; Kuji M; Tanioka T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2405-7. PubMed ID: 25731538
[TBL] [Abstract][Full Text] [Related]
29. [Successful resection of a gastrointestinal stromal tumor in the pelvis with imatinib mesylate as neoadjuvant therapy].
Nakajima N; Kato S; Usui Y; Shinozaki T; Soeda S; Kawakami M; Kim H; Hanai K; Hoshi A; Nomoto T; Terachi T; Sadahiro S
Hinyokika Kiyo; 2011 Mar; 57(3):135-9. PubMed ID: 21586885
[TBL] [Abstract][Full Text] [Related]
30. Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.
Haller F; Detken S; Schulten HJ; Happel N; Gunawan B; Kuhlgatz J; Füzesi L
Ann Surg Oncol; 2007 Feb; 14(2):526-32. PubMed ID: 17139461
[TBL] [Abstract][Full Text] [Related]
31. [Metastatic gastrointestinal stromal tumors responded to the treatment with STI571 after polysurgery for recurrent lesions--report of two cases].
Sasaki K; Doi T; Matsumoto G; Tsuruta K; Okamoto A; Funada N
Gan To Kagaku Ryoho; 2003 Jul; 30(7):1021-5. PubMed ID: 12894723
[TBL] [Abstract][Full Text] [Related]
32. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).
Fiore M; Palassini E; Fumagalli E; Pilotti S; Tamborini E; Stacchiotti S; Pennacchioli E; Casali PG; Gronchi A
Eur J Surg Oncol; 2009 Jul; 35(7):739-45. PubMed ID: 19110398
[TBL] [Abstract][Full Text] [Related]
33. Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection.
Cavaliere D; Vagliasindi A; Mura G; Framarini M; Giorgetti G; Solfrini G; Tauceri F; Padovani F; Milandri C; Dubini A; Ridolfi L; Ricci E; Verdecchia GM
Eur J Surg Oncol; 2007 Oct; 33(8):1044-6. PubMed ID: 17467951
[No Abstract] [Full Text] [Related]
34. [Gastrointestinal stromal tumors: a broad clinical spectrum from incidental -discovery to acute gastrointestinal bleeding].
Siewert E; Tietze L; Maintz C; Geier A; Dietrich CG; Matern S; Gartung C
Z Gastroenterol; 2004 Mar; 42(3):233-42. PubMed ID: 15022111
[TBL] [Abstract][Full Text] [Related]
35. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H
Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500
[TBL] [Abstract][Full Text] [Related]
36. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
[TBL] [Abstract][Full Text] [Related]
37. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
38. [Gastrointestinal stromal tumour: our experience].
Versaci A; Macrì A; Ieni A; Terranova M; Leonello G; Saladino E; Speciale G; Famulari C
Chir Ital; 2009; 61(2):161-9. PubMed ID: 19536989
[TBL] [Abstract][Full Text] [Related]
39. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
Rutkowski P; Nowecki Z; Nyckowski P; Dziewirski W; Grzesiakowska U; Nasierowska-Guttmejer A; Krawczyk M; Ruka W
J Surg Oncol; 2006 Mar; 93(4):304-11. PubMed ID: 16496358
[TBL] [Abstract][Full Text] [Related]
40. [A case of bleeding giant gastrointestinal stromal tumor of the stomach who achieved partial response by chemotherapy].
Takeuchi N; Nishida Y; Nomura Y; Makino T; Maeda T; Iida M; Otsuka A; Tada H; Nakamura T; Ichihara K
Gan To Kagaku Ryoho; 2012 Feb; 39(2):281-4. PubMed ID: 22333644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
